We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+14.6%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$500B
AUM Growth
+$33.8B
Cap. Flow
-$25.4B
Cap. Flow %
-5.08%
Top 10 Hldgs %
30.95%
Holding
15,795
New
1,585
Increased
6,018
Reduced
6,315
Closed
1,626

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.38B
2
NVDA icon
NVIDIA
NVDA
+$732M
3
AMZN icon
Amazon
AMZN
+$606M
4
DIS icon
Walt Disney
DIS
+$559M
5
T icon
AT&T
T
+$466M

Sector Composition

Rank Sector Weight
1 Technology 3.81%
2 Healthcare 2.95%
3 Financials 2.19%
4 Consumer Discretionary 2.15%
5 Industrials 1.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BDTX icon
13201
CALL
Black Diamond Therapeutics
BDTX
$103M
$7.31K ﹤0.01%
2,600
-15,000
-85% -$35.2K
GALT icon
13202
PUT
Galectin Therapeutics
GALT
$203M
$7.3K ﹤0.01%
+4,400
New +$8.53K
STRO icon
13203
CALL
Sutro Biopharma
STRO
$416M
$7.29K ﹤0.01%
170
+70
+70% +$2.22K
MYSZ icon
13204
My Size
MYSZ
$1.86M
$7.28K ﹤0.01%
+1,359
New +$7.88K
CTXR icon
13205
CALL
Citius Pharmaceuticals
CTXR
$21.4M
$7.26K ﹤0.01%
384
+172
+81% +$3.26K
ATER icon
13206
Aterian
ATER
$5.49M
$7.26K ﹤0.01%
+1,736
New +$6.7K
INBK icon
13207
PUT
First Internet Bancorp
INBK
$256M
$7.26K ﹤0.01%
300
-300
-50% -$5.8K
NAAS
13208
NaaS Technology Inc
NAAS
$55.6M
$7.25K ﹤0.01%
+15
New +$12.2K
ARVL
13209
CALL
DELISTED
Arrival Ordinary Shares
ARVL
$7.25K ﹤0.01%
+6,418
New +$7.36K
NUVB icon
13210
CALL
Nuvation Bio
NUVB
$2.22B
$7.25K ﹤0.01%
4,800
-19,900
-81% -$25.6K
WIT icon
13211
PUT
Wipro
WIT
$19.8B
$7.24K ﹤0.01%
2,600
+600
+30% +$1.46K
ATAI icon
13212
PUT
AtaiBeckley Inc
ATAI
$2.67B
$7.19K ﹤0.01%
5,100
-4,800
-48% -$5.97K
SST icon
13213
System1
SST
$13.8M
$7.18K ﹤0.01%
324
+229
+241% +$3.39K
IPW icon
13214
iPower
IPW
$690K
$7.17K ﹤0.01%
+66
New +$8.58K
PAY icon
13215
PUT
Paymentus
PAY
$5.03B
$7.15K ﹤0.01%
400
+200
+100% +$3.26K
DRRX
13216
PUT
DELISTED
DURECT Corp
DRRX
$7.14K ﹤0.01%
12,100
-1,900
-14% -$2.71K
LGF.B
13217
PUT
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$7.13K ﹤0.01%
700
-4,300
-86% -$36.9K
FFBC icon
13218
PUT
First Financial Bancorp
FFBC
$3.61B
$7.13K ﹤0.01%
300
-2,900
-91% -$60.1K
PROK icon
13219
PUT
ProKidney
PROK
$343M
$7.12K ﹤0.01%
+4,000
New +$8.58K
THCX
13220
CALL
DELISTED
AXS Cannabis ETF
THCX
$7.09K ﹤0.01%
+420
New +$6.97K
OVID icon
13221
CALL
Ovid Therapeutics
OVID
$489M
$7.08K ﹤0.01%
+2,200
New +$7.52K
FBRX icon
13222
Forte Biosciences
FBRX
$1.57B
$7.08K ﹤0.01%
+345
New +$4.82K
SBEV icon
13223
CALL
Splash Beverage Group
SBEV
$2.68M
$7.07K ﹤0.01%
80
-19
-19% -$1.81K
PRF icon
13224
PUT
Invesco FTSE RAFI US 1000 ETF
PRF
$9.98B
$7.04K ﹤0.01%
200
+100
+100% +$3.28K
CHRN
13225
CALL
ChronoScale Holdings
CHRN
$3.39B
$7K ﹤0.01%
187
+60
+47% +$1.14K

Similar funds

Citadel Advisors's Q4 2023 Portfolio in Review

As of Q4 2023, Citadel Advisors held 15,795 positions worth $500B, up 7.2% from $467B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Citadel Advisors withdrew a net $25.4B in Q4 2023, closing 1,626 positions and reducing 6,315 holdings. Its most notable exit was Activision Blizzard, an estimated $1.41B position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.8% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Citadel Advisors opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $129M.

  • Citadel Advisors's largest Q4 2023 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,167,658 shares worth $129M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $1.38B increase.
  • Citadel Advisors's biggest Q4 2023 reduction was Comcast, cutting an estimated $658M.
  • Citadel Advisors fully exited Activision Blizzard in Q4 2023, selling an estimated $1.41B.
  • Citadel Advisors's ten largest holdings make up 31% of its $500B portfolio in Q4 2023.
  • Citadel Advisors opened 1,585 new positions and closed 1,626 in Q4 2023.
  • Citadel Advisors's portfolio value rose 7.2% quarter-over-quarter to $500B.

Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.